PGP and glioblastoma: Indeed, SLNs have been proposed for use as innovative chemotherapeutic agent vehicles for experimental glioblastoma multiforme (GBM) treatment, owing to their ability to enhance drug uptake by cells and evade the Pgp efflux system.